index - Plateforme d’immortalisation MyoLine – CRM Accéder directement au contenu

Dernières publications

Chiffres clés

48 Publications with fulltext

Open Access

87 %

Mots clés

Exondys 51 Motor neuron Canine X-linked muscular dystrophy in Japan CXMD J Conjugation Neuromuscular junction CLS Myotonic dystrophy Autophagosome Coculture Fear response Autophagy DNM2 DsDNA break repair BMD Becker muscular dystrophy Gene network analysis CXCL12 Exon Skipping Eteplirsen MT RNA/DNA Editing LTβR Atrial cardiac defects Antisense morpholino Actin Immortalized dystrophic canine myoblast Fibroblast Allele-specific silencing CMS Dystrophin Lymphotoxin-β-receptor Duchenne muscular dystrophy Myogenesis Flavonoid Cell Therapy CRISPR/Cas9 Insulin Lamin A/C nuclei Human artificial chromosomes Acetylcholine receptor subunit epsilon DMD CTG⋅CAGn repeat Exon-skipping CFTR correctors Lamina-associated domain Drisapersen Glucocorticoid-induced muscle atrophy Becker muscular dystrophy BMD Duchenne muscular dystrophy DMD miRNA nNOS CXCR4 Adhesion Dynamin 2 Machine learning Gene therapy Human muscle stem/progenitor cells Immortalisation Myotube CDNA synthesis Migration Differentiation Emerin Duchenne Muscular Dystrophy Cell biology Gel electrophoresis Expanded repeats Skeletal muscle HDMD/Dmd-null mice DM1 myoblasts Bile acid FoxO Muscle Cell-penetrating peptide Antisense oligonucleotide ITSN1 Glucose MSCs Endocytosis RNA interference Chromatin Dominant centronuclear myopathy LRP4 Gut microbiota Clinical trial candidate screening Gene Therapy Mdx Laminographie Fibrosis Adeno-associated viral vector Alternative splicing Human Folding-defective proteins Exon skipping KLF15 Developmental biology Mdx52 mice BAF 3D co-culture FSHD Centronuclear myopathy Allele-specific silencing therapy ICU-acquired weakness Computer software